Search - tctmd.com

Displaying 861 - 880 of 1270

Sort: Relevancy | Date

News Daily News

Monthly Vitamin D Fails to Prevent CVD in Large Randomized Trial

Shelley Wood

April 07, 2017

News Daily News

A Deadly Diet: Half of US Deaths From Cardiometabolic Causes Linked to Dietary Habits

Michael O'Riordan

March 08, 2017

News Daily News

Herbals and the Heart: New Review Seeks to Sum Up Dearth of Data on Effects and Hazards

Shelley Wood

February 28, 2017

News Daily News

Four-in-One Blood Pressure Pill Shows Promise as Initial Therapy

Shelley Wood

February 24, 2017

News Daily News

Meta-analysis Adds Support to More Intensive Lowering of BP in Older Patients With Hypertension

Todd Neale

January 30, 2017

News Daily News

American Heart Association Annual Stats: Yet Again, CVD Is the Leading Killer

Shelley Wood

January 26, 2017

News Daily News

Meta-analysis Calls Into Question Strength of Guidance for RAS Blockade in Patients With Stable CAD

Todd Neale

January 19, 2017

News Daily News

Yet Another Set of Hypertension Guidelines Sow Confusion Surrounding BP Targets in Older Patients

Michael O'Riordan

January 17, 2017

News Daily News

Global Burden of Elevated Systolic Blood Pressure on the Rise

Michael O'Riordan

January 10, 2017

News Daily News

USPSTF: Counseling on Diet and Exercise Helpful but Not Mandatory for CVD Prevention

Caitlin E. Cox

December 02, 2016

News Daily News

Anemia Common in ACS Patients, Linked with Higher Mortality

Michael O'Riordan

November 23, 2016

News Daily News

New USPSTF Guidelines Recommend Statins in ‘Appropriately Selected’ Primary-Prevention Patients

Michael O'Riordan

November 13, 2016

News Daily News

La AHA Facilita las Interacciones Farmacológicas entre Estatinas y Fármacos contra la Enfermedad Cardiovascular

Michael O'Riordan

October 18, 2016

News Daily News

AHA 提供他汀类药物和心血管药物药物相互作用指导

Michael O'Riordan

October 18, 2016

News Daily News

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

Michael O'Riordan

October 18, 2016

News Daily News

In Older Breast Cancer Survivors, CVD Risk May Fly Below the Radar

L.A. McKeown

October 17, 2016

News Daily News

Midlife Hypertension Linked to Late-Life Cognitive Decline

Leah Lawrence

October 11, 2016

News Daily News

Low Diastolic Blood Pressure Linked to Subclinical Myocardial Damage and Coronary Events: ARIC Analysis

Michael O'Riordan

October 06, 2016

News Daily News

Chelation Encore: TACT2 Trial Gets Go-ahead for Controversial Post-MI Treatment in Diabetes

Shelley Wood

September 28, 2016

News Daily News

不同次复诊时收缩压大幅波动与死亡风险升高相关

Michael O'Riordan

September 27, 2016

Advertisement

Monthly Vitamin D Fails to Prevent CVD in Large Randomized Trial

A Deadly Diet: Half of US Deaths From Cardiometabolic Causes Linked to Dietary Habits

Herbals and the Heart: New Review Seeks to Sum Up Dearth of Data on Effects and Hazards

Four-in-One Blood Pressure Pill Shows Promise as Initial Therapy

Meta-analysis Adds Support to More Intensive Lowering of BP in Older Patients With Hypertension

American Heart Association Annual Stats: Yet Again, CVD Is the Leading Killer

Meta-analysis Calls Into Question Strength of Guidance for RAS Blockade in Patients With Stable CAD

Yet Another Set of Hypertension Guidelines Sow Confusion Surrounding BP Targets in Older Patients

Global Burden of Elevated Systolic Blood Pressure on the Rise

USPSTF: Counseling on Diet and Exercise Helpful but Not Mandatory for CVD Prevention

Anemia Common in ACS Patients, Linked with Higher Mortality

New USPSTF Guidelines Recommend Statins in ‘Appropriately Selected’ Primary-Prevention Patients

La AHA Facilita las Interacciones Farmacológicas entre Estatinas y Fármacos contra la Enfermedad Cardiovascular

AHA 提供他汀类药物和心血管药物药物相互作用指导

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

In Older Breast Cancer Survivors, CVD Risk May Fly Below the Radar

Midlife Hypertension Linked to Late-Life Cognitive Decline

Low Diastolic Blood Pressure Linked to Subclinical Myocardial Damage and Coronary Events: ARIC Analysis

Chelation Encore: TACT2 Trial Gets Go-ahead for Controversial Post-MI Treatment in Diabetes

不同次复诊时收缩压大幅波动与死亡风险升高相关

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content